Clinical Trial Update: Study of Human Umbilical Cord Mesenchymal Stem Cell in Patients With Cirrhosis Due to Hepatitis B (Compensation Stage) [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial investigating human umbilical cord mesenchymal stem cells for cirrhosis caused by hepatitis B in compensation stage, spanning Phase 1 and Phase 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis Due to Hepatitis

Drugs mentioned

• Human Umbilical Cord Mesenchymal Stem Cells

Snippet

Sponsor: Renmin Hospital of Wuhan University | Conditions: Cirrhosis Due to Hepatitis B | Phase 1, Phase 2 | Status: UNKNOWN